Abstract
Progeria is sporadic, very rare, autosomal dominant, deadly childhood disorder. It is one of the progeroid syndromes also known as Hutchinson–Gilford progeria syndrome (HGPS). Aging is a developmental process that begins with fertilization and ends up with death involving a lot of environmental and genetic factors. The disease firstly involves premature aging and then death from complications of atherosclerosis such as myocardial infarction, stroke, atherosclerosis, or heart failure. The lifespan of the patient is normally up to teen age or early twenties. It is usually not inherited because a patient normally dies before the age of reproduction. The most important genetic linkage between progeria and aging is shortening of telomere ends with each replication cycle. The patients are normally observed to have extremely short telomeres. Currently, 90% of the patients are said to have de novo point mutations in the LMNA gene that substitute cytosine with thymine and have been found in individuals with HGPS. Lmna encodes lamins A and C, and the A-type lamins have important structural function in the nuclear envelope. The most common type of HGPS mutation is located at codon 608 (G608G). It could not be diagnosed at birth, but after the age of 2 years, visible, prominent symptoms can be observed. Still, lot of research is needed to solve this mystery; hopefully, future research on HGPS would provide important clues for progeria and other fatal age-related disorders.
Similar content being viewed by others
References
Hutchinson J (1886) Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages in a boy whose mother had been almost totally bald from alopecia areata from the age six. Medicochir Trans 69:473–477
Gilford H (1897) On a condition of mixed premature and immature development. Med Chirurg Trans 80:17–45
Gilford H (1904) Progeria: a form of senilism. Practitioner 73:188–217
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith ACM, Perry MB, Brewer CC, Zalewski C et al (2010) Phenotype and course of Hutchinson–Gilford progeria syndrome. N Engl J Med 358(6):592–604. doi:10.1056/NEJMoa0706898Published in final edited form as: N Engl J Med. 2008 February 7
Hennekam RC (2006) Hutchinson–Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 140A:2603–2624. doi:10.1002/ajmg.a.31346
Sternberg S (2003) Gene found for rapid aging disease in children. USA Today. http://www.usatoday.com/news/science/2003-04-16-agin-gene_x.htm. Retrieved 2006–12-13
Steve Roach E, Miller VS (2004) Cambridge University Press, vol 36, p 150
Rakha P, Gupta A, Dhingra G, Nagpal M (2011) Hutchinson–Gilford progeria syndrome: a review. Der Pharmacia Sinica 2(1):110–117
Hsiao K-J (1998) Adv Clin Chem 33:10
Quick facts as of April 1, 2017. Progeria Research Foundation. https://www.progeriaresearch.org/quick-facts/. Accessed 14 June 2017
De Busk FL (1972) The Hutchinson-Gilford progeria syndrome. J Pediatr 90:697–724
Beauregard S, Gilchrest BA (1987) Syndromes of premature aging. Dermatol Clin 5:109–121
Brown WT, Kieras FJ, Houck GE Jr, Dutkowski R, Jenkins EC (1985) A comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome. Adv Exp Med Biol 190:229–244
Brown WT (1987) Premature aging syndromes. Curr Probl Dermatol 17:152–165
Korf B (2008) N Engl J Med 358(6):552–555
Rakha P et al (2011) Der Pharmacia Sinica 2(1):110–117
Balin AD (ed) (1989) Contribution of in vitro skin fibroblast studies from individuals with genetic disease that predispose to accelerated aging phenomena to our understanding of the aging process. Raven Press, New York, pp. 93–9l 19
Progeria Research Foundation (2016) https://www.progeriaresearch.org/meet-the-kids/. Accessed 14 June 2017
Pesce K, Rothe MJ (1996) The premature ageing syndromes. Clin Dermatol 14:161–170
Dyer CAE, Sinclair AJ (1998) The premature ageing syndromes: insights into the ageing process. Age Ageing 27:73–80
Bennett GCJ, Ebrahim S (1995) The essentials of health care in old age, 2nd edn. Oxford University Press, New York, pp. 3–10
Plasilova M, Chattopadhyay C, Pal P, Schaub NA, Buechner SA, Mueller H, Miny P, Ghosh A et al (2004) Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet 41:609–614
Smith ED, Kudlow BA, Frock RL, Kennedy BK (2005) A-type nuclear lamins, progerias and other degenerative disorders. Mech Ageing Dev 126:447–460
Kirkwood TB (2005) Understanding the odd science of aging. Cell 120:437–447
Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW (2005) DNA repair, genome stability, and aging. Cell 120:497–512
Decker ML, Chavez E, Vulto I, Lansdorp PM (2009) Telomere length in Hutchinson-Gilford progeria syndrome. Mech Ageing Dev 130(6):377–383
Silvera VM, Gordon LB, Orbach DB, Campbell SE, Machan JT, Ullrich NJ (2013) Imaging characteristics of cerebrovascular arteriopathy and stroke in Hutchinson-Gilford progeria syndrome. Am J Neuroradiol 34(5):1091–1097
Goss JR, Stolz DB, Robinson AR, Zhang M, Arbujas N, Robbins PD, Glorioso JC, Niedernhofer LJ (2010) Premature aging-related peripheral neuropathy in a mouse model of progeria. Mech Ageing Dev. doi:10.1016/j.mad.2011.04.010
Sarkar PK, Shinton RA (2001) Hutchinson-Gilford progeria syndrome. Postgrad Med J 77:312–317
Olteanu I, Crisan M, Crisan D, Kozan A (2009) Hutchinson-Gilford syndrome. Journal Medical Aradean 02:13–18
Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19(1):6–7
DeBusk FL (1972) The Hutchinson-Gilford progeria syndrome: report of 4 cases and review of the literature. J Pediatrics 80(4):697–724
Uitto J (2001) Searching for clues to premature aging. The workshop on Hutchinson–Gilford Progeria Syndrome was held at Bethesda, MD, USA, 28 and 29 November
Kumar S, Kumar A, Singla M, Singh A (2010) Hutchinson-Gilford syndrome (progeria). Int J Pharm Bio Sci 1(3)
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604
Dominguez-Gerpe L, Araijo-Vilar D (2008) Prematurely aged children; molecular alteration leading to Hutchinson-Gilford progeria and Werner syndromes. Current aging Sci 1:202–212
Hennekam RC (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 140:2603–2624
Ackerman J, Gilbet-Barness E (2002) Hutchinson-Gilford progeria syndrome: a pathologic study. Pediatr Pathol Mol Med 21:1–13
Ishii T (1976) Progeria: autopsy report of one case, with a review of pathologic findings reported in a literature. J Am Geriatr Soc 24:193–202
Corcoy R, Aris A, de Leiva A (1989) Fertility in a case of progeria. Am J Med Sci 297:383–384
Sadeghi-Nejad A, Demmer L (2007) Growth hormone therapy in progeria. J Pediatr Endocrinol Metab 20(5):633–637
Hennekam RC (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet 140:2603–2624
Arlan L (1971) Am Heart J 82:287–289
Gorlin RO, Sedano HO (1968) Progeria Hutchinson-Gilford syndrome. Mod Med 46:62
Batstone MD, Macleod AW (2002) Oral and maxillofacial surgical considerations for a case of Hutchinson-Gilford progeria. Int J Paediatr Dent 12:429–432
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604
Shiraishi I, Hayashi S, Hirai E, Onouchi Z, Hamaoka K (2001) Fatal pulmonary hypertension associated with an atypical case of Hunchinson-Gilford progeria. Pediatr Cardiol 22:530–533
Stehbens WE, Wakefield SJ, Gilbert-Barness E, Olson RE, Ackerman J (1999) Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol 8:29–39
Atkins L (1954) Progeria: report of a case with post-mortem findings. N Engl J Med 250:1065–1069
Ishii T (1976) Progeria: autopsy report of one case, with a review of pathologic findings reported in the literature. J Am Geriatr Soc 24:193–202
Corcoy R, Aris A, de Leiva A (1989) Fertility in a case of progeria. Am J Med Sci 297:383–384
DeBusk FL (1972) The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr 80:697–724
Gabr M, Hashem N, Hashem M, Fahmi A, Safouh M (1960) Progeria, a pathologic study. J Pediatr 57:70–77
Dyck JD, David TE, Burke B, Webb GD, Henderson MA, Fowler RS (1987) Management of coronary artery disease in Hutchinson-Gilford syndrome. J Pediatr 111:407–410
Khalifa MM (1989) Hutchinson–Gilford progeria syndrome: report of a Libyan family and evidence of autosomal recessive inheritance. Clin Genet 35:125–132
Maciel AT (1988) Evidence for autosomal recessive inheritance of progeria (Hutchinson Gilford). Am J Med Genet 31:483–487
Brown WT (1979) Human mutations affecting aging—a review. Mech Ageing Dev 9:325–336
Delgado Luengo W, Rojas Martinez A, Ortiz Lopez R et al (2002) Del(1)(q23) in a patient with Hutchinson–Gilford progeria. Am J Med Genet 113:298–301
Brown WT, Adbenur J, Goonewardena P et al (1990) Hutchinson–Gilford progeria syndrome: clinical and metabolic abnormalities (abstract). Am J Hum Genet 47:A50
De Sandre-Giovannoli A, Bernard R, Cau P et al (2003) Lamin A truncation in Hutchinson–Gilford progeria. Science 300:2055
Cao H, Hegele RA (2003) Lmna is mutated in Hutchinson–Gilford progeria (MIM 176670) but not in Wiedemann–Rautenstrauch progeroid syndrome (MIM 264090). J Hum Genet 48:271–274
Shanker P, Vishisanth P, Vijay Nath D, Naveen C, Kiran Kumar Y, Venkateshwarlu P (2010) Progeria. A brief review. Intr J Pharma & Bio Sciences 1(2)
Plasilova M, Chattopadhyay C, Pal P, Schaub NA, Buechner SA, Mueller H et al (2004) Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet 41:609–614
Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA (2004) Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 41:304–308
Fukuchi K, Katsuya T, Sugimoto K, Kuremura M, Kim HD, Li L et al (2004) LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome. J Med Genet 41:e67
Verstraeten VL, Broers JL, van Steensel MA, Zinn-Justin S, Ramaekers FC, Steijlen PM et al (2006) Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 15:2509–2522
Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y et al (2003) LMNA mutations in atypical Werner’s syndrome. Lancet 362:440–445
Cox LS, Faragher RG (2007) From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing. Cell Mol Life Sci 64:2620–2641
Scaffidi P, Misteli T (2006) Lamin A-dependent nuclear defects in human aging. Science 312(5776):1059–1063
Wilson KL, Berk JM (2010) The nuclear envelope at a glance. J Cell Sci 123:1973–1978
Vergnes L, Peterfy M, Bergo MO, Young SG, Reue K (2004) Lamin B1 is required for mouse development and nuclear integrity. Proc Natl AcadSci USA 101:10428–10433
Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL et al (2006) Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 281:25768–25780
Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268:16321–16326
Weber K, Plessmann U, Traub P (1989) Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett 257:411–414
Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Cote N et al (2006) Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest 116:743–752
Worman HJ, Ostlund C, Wang Y (2010) Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol 2:a000760
Worman HJ, Bonne G (2007) “Laminopathies”: a wide spectrum of human diseases. Exp Cell Res 313:2121–2133
The Human Gene Mutation Database (at the Institute of Medical Genetics in Cardiff). http://www.hgmd.cf.ac.uk/ac/all.php. Accessed 14 June 2017
Qin Z, Kalinowski A, Dahl KN, Buehler MJ (2011) Structure and stability of the lamin A tail domain and HGPS mutant. J Struct Biol. doi:10.1016/j.jsb.2011.05.015
Sullivan T et al (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147:913–920
Nikolova V et al (2004) Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 113:357–369
De Sandre-Giovannoli A et al (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot–Marie–Tooth disorder type 2) and mouse. Am J Hum Genet 70:726–736
Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86:967–1008
Fong LG, Ng JK, Meta M, Cote N, Yang SH, Stewart CL et al (2004) Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci U S A 101:18111–18116
Scaffidi P, Misteli T (2005) Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 11:440–445
Toth JI, Yang SH, Qiao X, Beigneux AP, Gelb MH, Moulson CL et al (2005) Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A 102:12873–12878
Gruber J, Lampe T, Osborn M, Weber K (2005) RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome. J Cell Sci 118:689–696
Subba RK (2007) Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Pract Neurol 3:162–172
Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X et al (2005) Genomic instability in laminopathy-based premature aging. Nat Med 11:780–785
Manju K, Muralikrishna B, Parnaik VK (2006) Expression of disease causing lamin A mutants impairs the formation of DNA repair foci. J Cell Sci 119:2704–2714. doi:10.1242/jcs.03009
Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, Erdos MR et al (2006) Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci U S A 103:8703–8708
Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM et al (2005) Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437:564–568
Atadja P, Wong H, Garkavtsev I, Veillette C, Riabowol K (1995) Increased activity of p53 in senescing fibroblasts. Proc Natl AcadSci USA 92:8348–8352
Kudlow BA, Kennedy BK, Monnat RJ Jr (2007) Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 8:394–404
Therizols P, Fairhead C, Cabal GG, Genovesio A, Olivo-Marin JC, Dujon B et al (2006) Telomere tethering at the nuclear periphery is essential for efficient DNA double strand break repair in subtelomeric region. J Cell Biol 172:189–199
Bridger JM, Kill IR (2004) Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 39:717–724
Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB et al (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl AcadSci USA 101:8963–8968
Hutchison CJ, Alvarez-Reyes M, Vaughan OA (2001) Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 114:9–19
Worman HJ, Gundersen GG (2006) Here come the SUNs: a nucleocytoskeletal missing link. Trends Cell Biol 16:67–69
Eriksson M et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423(6937):293–398
Scaffidi P, Misteli T (2005) Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 11(4):440–445
Cao K et al (2007) A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci U S A 104(12):4949–4954
McClintock D et al (2007) The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2(12):E1269
Eisch V, Lu X, Gabriel D, Djabali K (2016) Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts. Oncotarget 7(17):24700
Holzenberger M (2004) The GH/IGF-I axis and longevity. Eur J Endocrinol 151(Suppl 1):S23–S27
Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E et al (2006) A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444:1038–1043
Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-Herman M, Smoot LB, Gordon CM et al (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome. Proc Natl Acad Sci USA 109(41):16666–16671
Gordon LB, Massaro J, D’Agostino RB, Campbell SE, Brazier J, Brown WT, Kleinman ME, Kieran MW (2014) Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation 130(1):27–34 CIRCULATIONAHA-113
Gordon LB, Kleinman ME, Massaro JM, D'Agostino RB, Shappell H, Gerhard-Herman M, Smoot LB, Gordon CM et al (2016) Clinical trial of protein farnesylation inhibitors lonafarnib, pravastatin and zoledronic acid in children with Hutchinson-Gilford progeria syndrome. Circulation 134(2):114–125 CIRCULATIONAHA-116
Everolimus and lonafarnib. Single arm. Phase I: lonafarnib with escalating doses of everolimus to determine MTD. Phase II: lonafarnib plus everolimus at MTD (efficacy assessment). https://clinicaltrials.gov/ct2/show/NCT02579044?term=progeria+everolimus&rank=1. Accessed 14 June 2017
Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS (2011) Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 3(89):89ra58. doi:10.1126/scitranslmed.3002346
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmed, M.S., Ikram, S., Bibi, N. et al. Hutchinson–Gilford Progeria Syndrome: A Premature Aging Disease. Mol Neurobiol 55, 4417–4427 (2018). https://doi.org/10.1007/s12035-017-0610-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-017-0610-7